Results 1 to 10 of about 14,370 (210)

Demonstration of the FLASH Effect Within the Spread-out Bragg Peak After Abdominal Irradiation of Mice [PDF]

International Journal of Particle Therapy, 2021
Purpose: The effects of FLASH-level dose rates delivered at the spread-out Bragg peak (SOBP) on normal tissue damage in mice were investigated. Materials and Methods: Fifty nontumor-bearing mice received abdominal irradiation, 30 at FLASH dose rates (100
Tucker Evans, BS, James Cooley, PhD, Miles Wagner, MS, Tianning Yu, PhD, Townsend Zwart, PhD   +4 more
doaj   +1 more source

Radiation Exposure of Cardiac Conduction Nodes During Breast Proton Therapy [PDF]

International Journal of Particle Therapy, 2023
Purpose: The exposition of cardiac conduction system during breast radiation therapy has never been studied, despite the increasing use of intensity-modulated radiation therapy, which exposes larger volume to low-dose bath.
Pierre Loap, MD, Farid Goudjil, PhD, Vincent Servois, MD, Krassen Kirov, MD, Alain Fourquet, MD, Youlia Kirova, MD   +5 more
doaj   +1 more source

Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer [PDF]

International Journal of Particle Therapy, 2021
Purpose: External beam radiotherapy is used in a subset of high-risk patients with differentiated thyroid cancer (DTC). Recurrent, radioactive iodine (RAI)–refractory DTC carries a poor prognosis.
Nathan Y. Yu, MD, Aditya Khurana, BS, Daniel J. Ma, MD, Michelle A. Neben-Wittich, MD, Michael A. Golafshar, MS, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Robert L. Foote, MD, Samir H. Patel, MD   +8 more
doaj   +1 more source

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer [PDF]

International Journal of Particle Therapy, 2021
Purpose: We compared work outcomes in patients with oropharyngeal cancer (OPC), randomized to intensity-modulated proton (IMPT) versus intensity-modulated photon therapy (IMRT) for chemoradiation therapy (CRT).
Grace L. Smith, MD, PhD, MPH, Shuangshuang Fu, PhD, Matthew S. Ning, MD, MPH, Diem-Khanh Nguyen, BA, Paul M. Busse, MD, PhD, Robert L. Foote, MD, Adam S. Garden, MD, Gary B. Gunn, MD, Clifton D. Fuller, MD, PhD, William H. Morrison, MD, Gregory M. Chronowski, MD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Jack Phan, MD, PhD, Jay P. Reddy, PhD, James W. Snider III, MD, Samir H. Patel, MD, Sanford R. Katz, MD, Alexander Lin, MD, Nasiruddin Mohammed, MD, Roi Dagan, MD, MS, Nancy Y. Lee, MD, David I. Rosenthal, MD, Steven J. Frank, MD   +23 more
doaj   +1 more source

Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy [PDF]

International Journal of Particle Therapy, 2021
Purpose: To assess the performance of a proton-specific knowledge based planning (KBPP) model in creation of robustly optimized intensity-modulated proton therapy (IMPT) plans for treatment of patients with prostate cancer.
Yihang Xu, BS, Nellie Brovold, MS, Jonathan Cyriac, MS, Elizabeth Bossart, PhD, Kyle Padgett, PhD, Michael Butkus, PhD, Tejan Diwanj, MD, Adam King, MS, Alan Dal Pra, MD, Matt Abramowitz, MD, Alan Pollack, MD, Nesrin Dogan, PhD   +11 more
doaj   +1 more source

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

Advances in Radiation Oncology, 2021
Purpose: Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). Methods and Materials: A retrospective review was conducted on all patients who were treated with
Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD   +15 more
doaj   +1 more source

Risk of second primary cancer from proton arc therapy of pediatric brain tumors

Physics and Imaging in Radiation Oncology, 2023
Proton arc therapy (PAT) is currently explored for clinical implementation, despite its associated low-dose bath. This study therefore aimed at evaluating the risk of radiation-induced second primary cancer (SPC) for PAT in pediatric brain tumor patients.
Laura Toussaint, Daniel J Indelicato, Ludvig P Muren, Camilla H Stokkevåg   +3 more
doaj   +1 more source

Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer [PDF]

International Journal of Particle Therapy, 2021
Purpose: To report patient-reported outcomes (PROs) derived from the Functional Assessment of Cancer Therapy-Head and Neck (FACT-HN) tool, in patients with oropharynx cancer (OPC) treated with intensity-modulated proton therapy (IMPT) in the context of ...
Houda Bahig, MD, PhD, Brandon G. Gunn, MD, Adam S. Garden, MD, Rong Ye, MSc, Kate Hutcheson, PhD, David I. Rosenthal, MD, Jack Phan, MD, PhD, Clifton D. Fuller, MD, PhD, William H. Morrison, MD, PhD, Jay Paul Reddy, MD, PhD, Sweet Ping Ng, MBBS, FRANZCR, Neil D. Gross, MD, Erich M. Sturgis, MD, MPH, Renata Ferrarotto, MD, Maura Gillison, MD, PhD, Steven J. Frank, MD   +15 more
doaj   +1 more source

Treatment planning of total marrow irradiation with intensity-modulated spot-scanning proton therapy

Frontiers in Oncology, 2022
PurposeThe goal of this study is to investigate treatment planning of total marrow irradiation (TMI) using intensity-modulated spot-scanning proton therapy (IMPT).
Darren M. Zuro, Gabriel Vidal, James Nathan Cantrell, Yong Chen, Chunhui Han, Christina Henson, Salahuddin Ahmad, Susanta Hui, Imad Ali   +8 more
doaj   +1 more source

Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma [PDF]

International Journal of Particle Therapy, 2023
Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced
William M. Mendenhall, MD, Jonathan J. Beitler, MD, MBA, Nabil F. Saba, MD, FACP, Ashok R. Shaha, MD, FACS, Sandra Nuyts, MD, PhD, Primož Strojan, MD, Heleen Bollen, MD, Oded Cohen, MD, Robert Smee, MD, Sweet Ping Ng, MD, Avraham Eisbruch, MD, Wai Tong Ng, MD, Jessica M. Kirwan, MA, Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP   +13 more
doaj   +1 more source